EUR 0.39
(-6.68%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 671 Thousand EUR | 67099900.0% |
2022 | 1.00 EUR | 0.0% |
2021 | - EUR | 0.0% |
2020 | - EUR | -100.0% |
2019 | 386 Thousand EUR | -72.35% |
2018 | 1.39 Million EUR | 693.18% |
2017 | 176 Thousand EUR | 21.38% |
2016 | 145 Thousand EUR | -12.65% |
2015 | 166 Thousand EUR | -16.16% |
2014 | 198 Thousand EUR | 43.23% |
2013 | 138.23 Thousand EUR | 19.19% |
2012 | 115.98 Thousand EUR | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | - EUR | 0.0% |
2024 Q2 | 946 Thousand EUR | 0.0% |
2023 Q1 | - EUR | -100.0% |
2023 FY | - EUR | -100.0% |
2023 Q3 | - EUR | 0.0% |
2023 Q4 | - EUR | 0.0% |
2023 Q2 | - EUR | 0.0% |
2022 Q2 | - EUR | 0.0% |
2022 Q1 | - EUR | 0.0% |
2022 Q3 | - EUR | 0.0% |
2022 Q4 | 1.00 EUR | 0.0% |
2021 Q1 | - EUR | 0.0% |
2021 Q2 | 1.00 EUR | 0.0% |
2021 Q4 | - EUR | 0.0% |
2020 Q2 | 386 Thousand EUR | 0.0% |
2020 Q1 | - EUR | -100.0% |
2020 Q4 | - EUR | 0.0% |
2019 Q3 | 170 Thousand EUR | -17.87% |
2019 Q4 | 386 Thousand EUR | 127.06% |
2019 Q2 | 207 Thousand EUR | 0.0% |
2019 Q1 | - EUR | -100.0% |
2018 Q4 | 1.39 Million EUR | 0.0% |
2018 Q2 | 259 Thousand EUR | 0.0% |
2018 Q1 | - EUR | -100.0% |
2017 Q4 | 176 Thousand EUR | 0.0% |
2017 Q1 | - EUR | -100.0% |
2017 Q2 | 170 Thousand EUR | 0.0% |
2016 Q2 | 201 Thousand EUR | 0.0% |
2016 Q1 | - EUR | -100.0% |
2016 Q4 | 145 Thousand EUR | 0.0% |
2016 Q3 | 145 Thousand EUR | -27.86% |
2015 Q2 | 184.62 Thousand EUR | 0.0% |
2015 Q1 | 184.62 Thousand EUR | -6.76% |
2015 Q3 | 166 Thousand EUR | -10.09% |
2015 Q4 | 166 Thousand EUR | 0.0% |
2014 Q4 | 198 Thousand EUR | 0.0% |
2014 Q2 | 159.88 Thousand EUR | 0.0% |
2014 Q1 | 159.88 Thousand EUR | 15.66% |
2014 Q3 | 198 Thousand EUR | 23.84% |
2013 Q3 | 138.23 Thousand EUR | 0.0% |
2013 Q1 | - EUR | -100.0% |
2013 Q4 | 138.23 Thousand EUR | 0.0% |
2012 Q4 | 115.98 Thousand EUR | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Boiron SA | 96.76 Million EUR | 99.307% |
Laboratorios Farmaceuticos Rovi, S.A. | 337.96 Million EUR | 99.801% |
Vetoquinol SA | 103.53 Million EUR | 99.352% |
Valneva SE | 44.46 Million EUR | 98.491% |
AB Science S.A. | 336 Thousand EUR | -99.702% |
Nanobiotix S.A. | 200 Thousand EUR | -235.5% |
Vivoryon Therapeutics N.V. | 1.00 EUR | -67099900.0% |
BioSenic S.A. | - EUR | -Infinity% |
ABIVAX Société Anonyme | 1.00 EUR | -67099900.0% |
Formycon AG | 467 Thousand EUR | -43.683% |